chronic renal failure
Conditions
Interventions
Intervention in therapeutic conditions: HD with PES-25Daeco and online HDF with MFX-25U eco (one pre-dilution and one post-dilution), for a total of three treatments, one at a time.
Sponsors
Kawashima Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients on PES-25Daeco or MFX-25U eco Patients with pre-dialysis serum Alb concentration of 2.9 g/dL or higher Patients on stable maintenance dialysis Patients who can maintain a blood flow rate of 280 mL/min Patients with no access problems (blockage, stenosis, etc.) or puncture difficulties Patients who can give free and voluntary consent to participate in this study by themselves or by their proxies.
Exclusion criteria
Exclusion criteria: When consent cannot be obtained. The physician considers the patient to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of a1-MG removal rate, a1-MG removal and albumin leakage between PES-25Daeco (dialyzer: Nipro Corporation) and MFX-25U eco (hemodialyzer filter: Nipro Corporation) | — |
Countries
Japan
Contacts
Public ContactYusaku Tanaka
Kawashima Hospital Department of Clinical Engineering
Outcome results
None listed